Evidence map›Paper›PMID 42512386›Full record

ArticleCancers2026

A Clinically Applicable Unmixing Approach for Spectral MRD Detection in AML.

Julian-Philipp Waclawski, Isabell Arnhardt, Hendrik Fokken, Nadine Kattre, Daphne den Hartog, Alexander N Snel, Angele Kelder, Jessica Herbst, Martin G Sauer, Michael Stadler and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Julian-Philipp WaclawskiDepartment of Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School, 30625 Hannover, Germany.ORCID 0009-0002-5037-8020
Isabell ArnhardtDepartment of Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School, 30625 Hannover, Germany.
Hendrik FokkenDepartment of Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0002-5363-1354
Nadine KattreDepartment of Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School, 30625 Hannover, Germany.
Daphne den HartogDepartment of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Alexander N SnelDepartment of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Angele KelderDepartment of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Jessica HerbstDepartment of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany.ORCID 0009-0006-9097-5179
Martin G SauerDepartment of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany.
Michael StadlerDepartment of Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School, 30625 Hannover, Germany.
Michael HeuserDepartment of Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School, 30625 Hannover, Germany.
Costa BachasDepartment of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0001-5983-6193
Adrian SchwarzerDepartment of Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School, 30625 Hannover, Germany.
Tobias MaetzigDepartment of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0001-8259-3150

Funding

Deutsche José Carreras Leukämie-Stiftung 16 R/2021Else Kröner-Fresenius-Stiftung DigiStrucMed 2020_EKPK.20European Union 101104421 (IMPACT-AML; HORIZON-MISSION-CANCER)European Union 101136502 (RESOLVE; HORIZON-MISSION-CANCER)German Cancer Aid 70114189Verein für krebskranke Kinder Hannover e.V. n.a.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AMLhemodilutionleukemic stem cellsMRD diagnosticsspectral flow cytometryviability assessment

Identifiers

PMID42512386
PMCPMC13406482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.